Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MHC-II expression
Associations
(2)
News
Trials
C3 | Sensitive
C3 | Resistant
Show legend
Drug categories
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Immunotherapy
Cancel
Hodgkin Lymphoma
HER2 Negative Breast Cancer
nivolumab
C3
MHC-II expression
|
Hodgkin Lymphoma
|
nivolumab
pembrolizumab + durvalumab
C3
MHC-II expression
|
HER2 Negative Breast Cancer
|
pembrolizumab + durvalumab
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
